Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Perry who wrote (1955)	5/2/1998 3:38:00 PM
From: erin4	Read Replies (1) \| Respond to of 9523

What the Barrons critiques haven't realized yet is that Viagra (to quote the Smith Barney comment yesterday) is not just a new drug its a new PHENOMENON!! There is a vast secret pool of impotent and marginally impotent men ,mostly over 50, who are just now being heard at the pharmicist counter clamoring for Viagra. Also there is starting to be heard from women who have had hysterectomies and other mainly older women, that Vitamin V helps them have an orgasm much more readily. When not if Viagra is approved for women in the next year or so its market will increase again and this is just in the USA.

To: Perry who wrote (1955)	5/2/1998 3:45:00 PM
From: Anthony Wong	Read Replies (1) \| Respond to of 9523

Perry, I read the Barrons cover article. Today Merck may be undervalued compared to Pfizer, but not in 3 or 4 years' time. Pfizer has more potentially blockbuster drugs in the pipeline and its present blockbusters have a long way to go before they are off-patent. I thought we are talking about future growth here, or what else to account for their recommendations of internet stocks as long term buys? I see some sort of Pfizer/Viagra bashing appearing (not only in Barrons, but appearing in other places as well). Are they trying to hold down the stock price?